| 翻訳と辞書 |
| Kevin Slawin ： ウィキペディア英語版 |
Kevin Slawin
Kevin M. Slawin (born 1961) is an American physician and the founder of Bellicum Pharmaceuticals and the Vanguard Urologic Institute at Memorial Hermann Medical Group. He is also the Director of Urology at Memorial Hermann Hospital. Slawin specializes in the diagnosis and treatment of urologic cancers and robotic surgery. He is also the co-inventor on several patents related to the advancement of prostate cancer diagnosis, staging and treatment〔(【引用サイトリンク】url = http://www.chron.com/news/health/article/New-prostate-cancer-test-gives-more-specific-5578350.php )〕 and to the cellular immunotherapy of cancer.
== Education ==
He graduated with a Bachelor of Arts degree in Biochemistry from Columbia University,〔(【引用サイトリンク】Columbia College Today )〕 and gained his medical degree in 1986 from Columbia College of Physicians and Surgeons.〔(【引用サイトリンク】America's Top Doctors - The Best in American Medicine )〕 Later, he was awarded a two-year fellowship, from 1992-1994, as an American Foundation of Urologic Disease (AFUD) scholar at Baylor College of Medicine〔 to continue to study the development and treatment of prostate cancer.〔(【引用サイトリンク】url = http://www.guardian.co.tt/news/2013-06-13/prostate-cancer-worry-tt )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Kevin Slawin」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|